These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 6244234)

  • 1. NC37-R1 Epstein-Barr virus (EBV): a possible recombinant between intracellular NC37 viral DNA and superinfecting P3HR-1 EBV.
    Fresen KO; Cho MS; Gissmann L; zur Hausen H
    Intervirology; 1980; 12(6):303-10. PubMed ID: 6244234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recovery of transforming EBV from non-producer cells after superinfection with non-transforming P3HR-1 EBV.
    Fresen KO; Cho MS; zur Hausen H
    Int J Cancer; 1978 Oct; 22(4):378-83. PubMed ID: 212377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiplicity-dependent biological and biochemical properties of Epstein-Barr virus (EBV) rescued from non-producer lines after superinfection with P3HR-1 EBV.
    Cho MS; Fresen KO; zur Hausen H
    Int J Cancer; 1980 Sep; 26(3):357-63. PubMed ID: 6270006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An EBNA-negative, EBV-genome-positive human lymphoblast cell line in which superinfecting EBV DNA is not maintained.
    Reisman D; Sugden B
    Virology; 1984 Aug; 137(1):113-26. PubMed ID: 6089410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The interaction of non-transforming Epstein-Barr virus (EBV) with cell-associated EBV DNA in superinfected lymphoblastoid cell lines.
    Stoerker J; Yajima Y; Glaser R
    Int J Cancer; 1982 Oct; 30(4):385-92. PubMed ID: 6292115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epstein-Barr virus (P3HR-1) defective DNA codes for components of both the early antigen and viral capsid antigen complexes.
    Cho MS; Gissmann L; Hayward SD
    Virology; 1984 Aug; 137(1):9-19. PubMed ID: 6089423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of Epstein-Barr virus nuclear antigen(s) in different cell lines by radioimmunoelectrophoresis.
    Sculley TB; Spelsberg TC; Pearson GR
    Intervirology; 1984; 22(4):191-200. PubMed ID: 6096291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure of defective DNA molecules in Epstein-Barr virus preparations from P3HR-1 cells.
    Cho MS; Bornkamm GW; zur Hausen H
    J Virol; 1984 Jul; 51(1):199-207. PubMed ID: 6328039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epstein-Barr virus with transforming and early antigen-inducing ability originating from nasopharyngeal carcinoma: mapping of the viral genome.
    Sato H; Takimoto T; Hatano M; Pagano JS; Raab-Traub N
    J Gen Virol; 1989 Mar; 70 ( Pt 3)():717-27. PubMed ID: 2543756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epstein-Barr virus with heterogeneous DNA disrupts latency.
    Miller G; Rabson M; Heston L
    J Virol; 1984 Apr; 50(1):174-82. PubMed ID: 6321789
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epstein-Barr virus recombinants from overlapping cosmid fragments.
    Tomkinson B; Robertson E; Yalamanchili R; Longnecker R; Kieff E
    J Virol; 1993 Dec; 67(12):7298-306. PubMed ID: 8230453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. U2 region of Epstein-Barr virus DNA may encode Epstein-Barr nuclear antigen 2.
    Dambaugh T; Hennessy K; Chamnankit L; Kieff E
    Proc Natl Acad Sci U S A; 1984 Dec; 81(23):7632-6. PubMed ID: 6209719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amplification of Epstein-Barr virus (EBV) DNA by superinfection with a strain of EBV derived from nasopharyngeal carcinoma.
    Sato H; Takimoto T; Pagano JS; Raab-Traub N
    J Virol; 1988 Sep; 62(9):3288-94. PubMed ID: 2841481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of epstein-Barr virus (EBV) of P3HR-1: isolation of EBV with EBNA induction ability in human cord lymphocytes and without EA induction ability in Raji cells.
    Yano S; Tanaka A; Takada K; Fujiwara S; Osato T; Nonoyama M
    Virology; 1982 Jun; 119(2):392-8. PubMed ID: 6281981
    [No Abstract]   [Full Text] [Related]  

  • 15. [Structural organization of the Epstein-Barr virus genome].
    D'iachenko AG
    Eksp Onkol; 1984; 6(4):3-10. PubMed ID: 6209094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Palindromic structure and polypeptide expression of 36 kilobase pairs of heterogeneous Epstein-Barr virus (P3HR-1) DNA.
    Jenson HB; Rabson MS; Miller G
    J Virol; 1986 May; 58(2):475-86. PubMed ID: 3009861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of Epstein-Barr virus strains of different origin by analysis of the viral DNAs.
    Bornkamm GW; Delius H; Zimber U; Hudewentz J; Epstein MA
    J Virol; 1980 Sep; 35(3):603-18. PubMed ID: 6252328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epstein-Barr virus DNA XII. A variable region of the Epstein-Barr virus genome is included in the P3HR-1 deletion.
    King W; Dambaugh T; Heller M; Dowling J; Kieff E
    J Virol; 1982 Sep; 43(3):979-86. PubMed ID: 6292475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Productive Epstein-Barr viral infection of the human lymphoblastoid cell line 6410 with release of early antigen inducing and transforming virus.
    Traul KA; Stephens R; Gerber P; Peterson WD
    Int J Cancer; 1977 Aug; 20(2):247-55. PubMed ID: 197026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two strains of Epstein-Barr virus (B95-8 and a P3HR-1 subclone) that lack defective genomes induce early antigen and cause abortive infection of Raji cells.
    Lin JC; Raab-Traub N
    J Virol; 1987 Jun; 61(6):1985-91. PubMed ID: 3033325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.